These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 16533140

  • 21. Neuropsychological and MRI measures predict short-term evolution in benign multiple sclerosis.
    Portaccio E, Stromillo ML, Goretti B, Zipoli V, Siracusa G, Battaglini M, Giorgio A, Bartolozzi ML, Guidi L, Sorbi S, Federico A, Amato MP, De Stefano N.
    Neurology; 2009 Aug 18; 73(7):498-503. PubMed ID: 19641173
    [Abstract] [Full Text] [Related]

  • 22. Is late-onset multiple sclerosis associated with a worse outcome?
    Tremlett H, Devonshire V.
    Neurology; 2006 Sep 26; 67(6):954-9. PubMed ID: 17000960
    [Abstract] [Full Text] [Related]

  • 23. Multiple sclerosis: early prognostic guidelines.
    Kraft GH, Freal JE, Coryell JK, Hanan CL, Chitnis N.
    Arch Phys Med Rehabil; 1981 Feb 26; 62(2):54-8. PubMed ID: 7235886
    [Abstract] [Full Text] [Related]

  • 24. Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis.
    Agosta F, Rovaris M, Pagani E, Sormani MP, Comi G, Filippi M.
    Brain; 2006 Oct 26; 129(Pt 10):2620-7. PubMed ID: 16951409
    [Abstract] [Full Text] [Related]

  • 25. Gender as a prognostic factor and its impact on the incidence of multiple sclerosis in Lorraine, France.
    Debouverie M.
    J Neurol Sci; 2009 Nov 15; 286(1-2):14-7. PubMed ID: 19691994
    [Abstract] [Full Text] [Related]

  • 26. Plasma exchange for acute attacks of CNS demyelination: Predictors of improvement at 6 months.
    Llufriu S, Castillo J, Blanco Y, Ramió-Torrentà L, Río J, Vallès M, Lozano M, Castellà MD, Calabia J, Horga A, Graus F, Montalban X, Saiz A.
    Neurology; 2009 Sep 22; 73(12):949-53. PubMed ID: 19770470
    [Abstract] [Full Text] [Related]

  • 27. Development of biomarkers in multiple sclerosis.
    Bielekova B, Martin R.
    Brain; 2004 Jul 22; 127(Pt 7):1463-78. PubMed ID: 15180926
    [Abstract] [Full Text] [Related]

  • 28. Prognosis of the individual course of disease--steps in developing a decision support tool for Multiple Sclerosis.
    Daumer M, Neuhaus A, Lederer C, Scholz M, Wolinsky JS, Heiderhoff M, Sylvia Lawry Centre for Multiple Sclerosis Research.
    BMC Med Inform Decis Mak; 2007 May 08; 7():11. PubMed ID: 17488517
    [Abstract] [Full Text] [Related]

  • 29. A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis.
    Rovira A, Swanton J, Tintoré M, Huerga E, Barkhof F, Filippi M, Frederiksen JL, Langkilde A, Miszkiel K, Polman C, Rovaris M, Sastre-Garriga J, Miller D, Montalban X.
    Arch Neurol; 2009 May 08; 66(5):587-92. PubMed ID: 19433658
    [Abstract] [Full Text] [Related]

  • 30. Clinical characteristics of multiple sclerosis in Lebanon.
    Yamout B, Barada W, Tohme RA, Mehio-Sibai A, Khalifeh R, El-Hajj T.
    J Neurol Sci; 2008 Jul 15; 270(1-2):88-93. PubMed ID: 18367208
    [Abstract] [Full Text] [Related]

  • 31. Clinically isolated syndromes: predicting and delaying multiple sclerosis.
    Thrower BW.
    Neurology; 2007 Jun 12; 68(24 Suppl 4):S12-5. PubMed ID: 17562845
    [Abstract] [Full Text] [Related]

  • 32. Starting and stopping treatment for seizures and epilepsy.
    Chadwick D.
    Epilepsia; 2006 Jun 12; 47 Suppl 1():58-61. PubMed ID: 17044828
    [Abstract] [Full Text] [Related]

  • 33. Predicting secondary progression in relapsing-remitting multiple sclerosis: a Bayesian analysis.
    Bergamaschi R, Berzuini C, Romani A, Cosi V.
    J Neurol Sci; 2001 Aug 15; 189(1-2):13-21. PubMed ID: 11535229
    [Abstract] [Full Text] [Related]

  • 34. Starting early: MRI evidence of gray matter atrophy in children with multiple sclerosis.
    Banwell BL, Sled JG.
    Neurology; 2008 Mar 25; 70(13 Pt 2):1065-6. PubMed ID: 18362266
    [No Abstract] [Full Text] [Related]

  • 35. [Prognostic criteria in multiple sclerosis].
    Poser S.
    Fortschr Med; 1975 Oct 23; 93(30):1481-3. PubMed ID: 1225806
    [Abstract] [Full Text] [Related]

  • 36. Factors associated with the risk of secondary progression in multiple sclerosis.
    Koch M, Uyttenboogaart M, van Harten A, De Keyser J.
    Mult Scler; 2008 Jul 23; 14(6):799-803. PubMed ID: 18573840
    [Abstract] [Full Text] [Related]

  • 37. [Advances in the treatment of multiple sclerosis?].
    Tackenberg B, Himmerich H, Wellek A, Oertel WH, Sommer N.
    MMW Fortschr Med; 2007 May 21; 149 Suppl 2():51-5. PubMed ID: 17724968
    [Abstract] [Full Text] [Related]

  • 38. Multiple sclerosis in children: clinical, diagnostic, and therapeutic aspects.
    Rostásy K.
    Int Rev Neurobiol; 2007 May 21; 79():269-79. PubMed ID: 17531845
    [Abstract] [Full Text] [Related]

  • 39. [Clinical phenomena in early and late-onset multiple sclerosis].
    Marforio S.
    Minerva Med; 1977 Feb 04; 68(6):405-12. PubMed ID: 190562
    [No Abstract] [Full Text] [Related]

  • 40. Progression in multiple sclerosis: further evidence of an age dependent process.
    Koch M, Mostert J, Heersema D, De Keyser J.
    J Neurol Sci; 2007 Apr 15; 255(1-2):35-41. PubMed ID: 17331540
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.